Invention Grant
- Patent Title: Agent for use in the treatment of glioma
-
Application No.: US17568757Application Date: 2022-01-05
-
Publication No.: US12029789B2Publication Date: 2024-07-09
- Inventor: Matthias Osswald , Wolfgang Wick , Frank Winkler , Erik Jung , Jonas Blaes
- Applicant: DC EUROPA LIMITED
- Applicant Address: GB Cambridge
- Assignee: Universität Heidelberg
- Current Assignee: Universität Heidelberg
- Current Assignee Address: DE Heidelberg
- Agency: Scully, Scott, Murphy & Presser, P.C.
- Priority: EP 002323 2015.08.04
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K31/13 ; A61K31/155 ; A61K31/16 ; A61K31/495 ; A61K31/497 ; A61K31/4985 ; A61K31/515 ; A61K31/522 ; A61K31/5377 ; A61K31/7105 ; A61K31/713 ; A61P35/00 ; C12N15/113
Abstract:
The present invention relates to agents for use in the treatment of glioma, in particular astrocytoma WHO II° and III°, as well as IV° (glioblastoma), in a subject.
Public/Granted literature
- US20220202936A1 AGENT FOR USE IN THE TREATMENT OF GLIOMA Public/Granted day:2022-06-30
Information query
